Bleeding Time in Rats: A Comparison of Different Experimental Conditions

 

PDF Download Buy Article Permissions and Reprints

Summary

The tail bleeding time (BT) in rats definitely varies according to the method applied. Of the various variables that may influence BT, we have evaluated the position (horizontal or vertical) of the tail, the environment (air or saline), the temperature (4°, 23° or 37° C) and the type of anaesthesia. Transection of the tail tip cannot be used to screen drugs active on platelet function since it is sensitive to coagulation defects. Template BT in contrast is not modified by heparin and is sensitive to defects of platelet number and function (“storage pool disease”, dipyridamole-like drugs, exogenous prostacyclin). In contrast the test fails to detect aspirin-induced platelet dysfunction. The evidence reported indicates that thromboxane A₂-prostacyclin balance is not a factor regulating BT. Aspirin treatment however may be a precipitating factor when associated with other abnormalities of platelet function.

Template BT is a valid screening test for platelet disorders and for antiplatelet drugs.

• References

• 1 Stella L, Donati MB, de Gaetano G. Bleeding time in laboratory animals. I. Aspirin does not prolong bleeding time in rats. Thromb Res 1975; 7: 709-716
  CrossrefPubMedGoogle Scholar
• 2 De Clerck F, Goossens J, Reneman R. Effects of anti-inflammatory, anticoagulant and vasoactive compounds on tail bleeding time, whole blood coagulation time and platelet retention by glass beads in rats. Thromb Res 1976; 8: 179-193
  PubMedGoogle Scholar
• 3 Davis JW, Phillips PE, Ellison JM, Lucas SR. Effect of aspirin on bleeding time and survival of rats after head trauma. J Med (Basel) 1974; 5: 229-233
  PubMedGoogle Scholar
• 4 Minsker DH, Kling PJ. Bleeding time in rats is prolonged by aspirin. Thromb Res 1977; 10: 619-622
  CrossrefPubMedGoogle Scholar
• 5 Dejana E, Callioni A, Quintana A, de Gaetano G. Bleeding time in laboratory animals, II. A comparison of different assay conditions in rats. Thromb Res 1979; 15: 191-197
  CrossrefPubMedGoogle Scholar
• 6 Bowie EJW, Owen Jr CA. The bleeding time. Prog Hemostasis Thromb 1974; 2: 249-271
  PubMedGoogle Scholar
• 7 Copley AL. Editorial: Bleeding time, other in vivo hemostasis tests and the arrest of hemorrhage. Thromb Res 1974; 4: 1-23
  PubMedGoogle Scholar
• 8 Bonaccorsi A, Dejana E, Quintana A. Organ blood flow measured with microspheres in the unanesthetized rat: effects of three room temperatures. J. Pharmacol Methods 1978; 1: 321-328
  CrossrefPubMedGoogle Scholar
• 9 Dejana E, Quintana A, Callioni A, de Gaetano G. Bleeding time in laboratory animals. III. Do tail bleeding times in rats only measure a platelet defect? (The aspirin puzzle). Thromb Res 1979; 15: 199-207
  CrossrefPubMedGoogle Scholar
• 10 Villa S, Livio M, de Gaetano G. The inhibitory effect of aspirin on platelet and vascular prostaglandins in rats cannot be completely dissociated. Br J Haematol 1979; 42: 425-431
  CrossrefPubMedGoogle Scholar
• 11 Tschopp TB, Weiss HJ. Decreased ATP, ADP and serotonin in young platelets of fawn-hooded rats with storage pool disease. Thrombos Diathes Haemorrh 1974; 32: 670-677
  PubMedGoogle Scholar
• 12 Reyers-Degli InnocentiI, Poggi A, de Gaetano G. Platelet aggregation and haemolysis induced in rats by intravenous infusion of ADP – effect of potentially antithrombotic drugs. Scand J Haematol 1974; 13: 331-337
  PubMedGoogle Scholar
• 13 Tomikawa M, Ashida S, Kakihata K, Abiko Y. Anti-thrombotic action of ticlopidine, a new platelet aggregation inhibitor. Thromb Res 1978; 12: 1157-1164
  CrossrefPubMedGoogle Scholar
• 14 Dejana E, Barbieri B, de Gaetano G. “Aspirinated” platelets are hemostatic in thrombocytopenic rats with “nonaspirinated” vessel walls – evidence from an exchange transfusion model. Blood 1980; 56: 959-962
  PubMedGoogle Scholar
• 15 Villa S, de Gaetano G. Bleeding time in laboratory animals. IV. Effects of prostacyclin, pyrimido-pyrimidine compounds and aspirin in rats. Thromb Res 1979; 15: 727-732
  CrossrefPubMedGoogle Scholar
• 16 Moncada S, Korbut R. Dipyridamole and other phosphodiesterase inhibitors act as antithrombotic agents by potentiating endogenous prostacyclin. Lancet 1978; 1: 1286-1289
  PubMedGoogle Scholar
• 17 Cazenave JP, Kinlough-Rathbone RL, Packham MA, Mustard JF. The effect of acetylsalicylic add and indomethacin on rabbit platelet adherence to collagen and the subendothelium in the presence of a low or high hematocrit. Thromb Res 1978; 13: 971-981
  CrossrefPubMedGoogle Scholar
• 18 Preston FE, Whipps S, Jackson CA, French AJ, Wyld PJ, Stoddard CJ. Inhibition of prostacyclin and platelet thromboxane A₂ after low-dose aspirin. N Engl J Med 1981; 304: 76-79
  CrossrefPubMedGoogle Scholar
• 19 Kaneshiro MM, Mielke Jr CH, Kasper CK, Rapaport SI. Bleeding time after aspirin in disorders of intrinsic clotting. N Engl J Med 1969; 281: 1039-1042
  CrossrefPubMedGoogle Scholar
• 20 Stuart MJ, Miller ML, Davey FR, Wolk JA. The post-aspirin bleeding time: a screening test for evaluating haemostatic disorders. Br J Haematol 1979; 43: 649-659
  CrossrefPubMedGoogle Scholar
• 21 Dejana E, Barbieri B, Cerletti C, Livio M, de Gaetano G. Impaired thromboxane production by newly formed platelets after aspirin administration to thrombocytopenic rats. Br J Haematol 1980; 46: 465-469
  CrossrefPubMedGoogle Scholar